𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro characterization of hepatocyte growth factor release from PHBV/PLGA microsphere scaffold

✍ Scribed by Xin Hao Zhu; Chi-Hwa Wang; Yen Wah Tong


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
468 KB
Volume
89A
Category
Article
ISSN
1549-3296

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Polymer scaffolds which can support cells to grow as well as deliver growth factors to the cells simultaneously have great potential for the successful regeneration of failed tissues. As popularly used vehicles to deliver anti‐cancer drugs and growth factors, microspheres also show many advantages as substrates to guide the growth of cells. Therefore, we aimed to examine the feasibility of using microspheres as ideal scaffolds for liver tissue engineering. To determine the capabilities of previously used microsphere scaffold to deliver growth factors simultaneously, this work investigated a long‐term (about three months) release of bovine serum albumin (BSA) from microsphere scaffolds fabricated by using two different polymers, poly(3‐hydroxybutyrate‐co‐3‐hydroxyvalerate) (PHBV, 8% PHV), poly(lactide‐co‐glycolide) acid (PLGA, 5050) and a blend of PLGA and PHBV. BSA served as a model for hepatocyte growth factor (HGF) since both proteins have similar molecular weights and hydrophilicity. Furthermore, HGF was encapsulated into the PLGA/PHBV composite microsphere with a core‐shell structure, and sustained delivery of HGF with maintained bioactivity was achieved for at least 40 days. The moderate degradation rate (about 55% loss of the initial mass) and well‐preserved structure after three months of incubation indicated that the PLGA/PHBV composite microspheres would therefore be more suitable than the pure PHBV or PLGA microspheres as a scaffold for engineering liver tissue. © 2008 Wiley Periodicals, Inc. J Biomed Mater Res, 2009


📜 SIMILAR VOLUMES


In vitro release of vascular endothelial
✍ Anthony Z. Faranesh; Monet T. Nastley; Cristina Perez de la Cruz; Michael F. Hal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 1 views

## Abstract A drug delivery vehicle was constructed that could be visualized noninvasively with MRI. The biodegradable polymer poly(DL‐lactic‐co‐glycolic acid) (PLGA) was used to fabricate microspheres containing vascular endothelial growth factor (VEGF) and the MRI contrast agent gadolinium diethy

In vitro growth factor release from inje
✍ W. J. E. M. Habraken; O. C. Boerman; J. G. C. Wolke; A. G. Mikos; J. A. Jansen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

## Abstract To improve the __in vivo__ resorption of an injectable calcium phosphate cement (CPC) for bone tissue engineering purposes, in previous experiments macroporosity was introduced by the __in situ__ degradation of incorporated gelatin microspheres. Gelatin microspheres are also suitable ca

Characterization of DNA release from com
✍ F. Kurtis Kasper; Erin Jerkins; Kazuhiro Tanahashi; Michael A. Barry; Yasuhiko T 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 403 KB 👁 1 views

## Abstract This research investigates the release of plasmid DNA from novel hydrogel composites of oligo(poly(ethylene glycol) fumarate) (OPF) and cationized gelatin microspheres (CGMS), as well as the swelling and degradation of these materials __in vitro__. The release of total DNA and of double

Synthesis, characterization, and in vitr
✍ M. Sivakumar; K. Panduranga Rao 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

## Abstract This article describes the development of a new crosslinked poly(methyl methacrylate‐2‐hydroxyethyl methacrylate) copolymeric core–shell hydrogel microsphere incorporated with ibuprofen for potential applications in bone implants. Initially poly(methyl methacrylate) (PMMA) core microsph

Effect of controlled release of fibrobla
✍ Shingo Nakamura; Masaki Nambu; Takamitsu Ishizuka; Hidemi Hattori; Yasuhiro Kana 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 316 KB 👁 2 views

## Abstract We produced a chitosan/fucoidan micro complex‐hydrogel as a carrier for controlled release of heparin binding growth factors such as fibroblast growth factor (FGF)‐2. Material consisting of a soluble chitosan (CH‐LA) mixed with fucoidan yielded a water‐insoluble and injectable hydrogel